Article in Comparative medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
JoAnn L YeeCalifornia National Primate Research Center, University of California, Davis, California.
Richard F GrantWashington National Primate Research Center, University of Washington, Seattle, Washington.
Koen K A Van RompayCalifornia National Primate Research Center, University of California, Davis, California.
Jeffrey A RobertsCalifornia National Primate Research Center, University of California, Davis, California.
LaRene KullerWashington National Primate Research Center, University of Washington, Seattle, Washington.
Jesse L CunninghamCalifornia National Primate Research Center, University of California, Davis, California.
Joe H SimmonsMichale E. Keeling Center for Comparative Medicine and Research, University of Texas MD Anderson Cancer Center, Bastrop, Texas.
James F PapinDepartment of Pathology, Division of Comparative Medicine, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma.
Funding
Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Viral Testing CoreU42OD010990 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Rhonda S Oates, Jeffrey A Roberts · 2012 to 2026
$20.1M
Specific Pathogen Free Baboon Research Resource (SPFBRR) - Bridge Funding Administrative SupplementP40OD024628 · OD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WILLIAM D HOPKINS · 2017 to 2026
$15.7M
Baboon Research Resource ProgramP40OD010988 · OD · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BANKS, RON E · 2012 to 2018
$9.0M
OUHSC Specific Pathogen Free Baboon Research ResourceP40OD010431 · OD · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BANKS, RON E, PAPIN, JAMES F · 2013 to 2017
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
In vitro and In vivo Susceptibility of Baboons ( · full record | OpenQuestion